The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Gaviscon Peppermint Chewable Tablets Sodium alginate 250mg Sodium hydrogen Carbonate 133.5mgCalcium Carbonate 80mg



Reckitt Benckiser Ireland LtdPA0979/015/004

Main Information

Trade NameGaviscon Peppermint Chewable Tablets Sodium alginate 250mg Sodium hydrogen Carbonate 133.5mgCalcium Carbonate 80mg
Active SubstancesSodium alginate
Sodium hydrogen carbonate
Calcium carbonate
Dosage FormChewable tablet
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/015/004

Group Information

ATC CodeA02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
A02BX13 alginic acid

Status

License statusAuthorised
Licence Issued22/12/2004
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back